There is a major drug interaction between Plavix (clopidogrel) and Nexium (esomeprazole).
GENERALLY AVOID: Coadministration with proton pump inhibitors (PPIs) may reduce the cardioprotective effects of clopidogrel. The proposed mechanism is PPI inhibition of the CYP450 2C19-mediated metabolic bioactivation of clopidogrel. This is consistent with studies that reported decreased effectiveness of clopidogrel in patients who have common genetic polymorphisms of CYP450 2C19 resulting in reduced or absent enzyme activity.
MANAGEMENT: Until further data are available, patients treated with clopidogrel should preferably avoid the use of proton pump inhibitors. H2-receptor antagonists or antacids should be considered whenever possible.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 2 Aug 2010 • 2 answers
Posted 17 Jan 2011 • 2 answers
Posted 15 Jun 2011 • 1 answer
Posted 6 Oct 2011 • 1 answer
Posted 14 Apr 2015 • 1 answer